3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Diseases
1
Neoplasms by Site
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Interventions
Cyclophosphamide
2
pembrolizumab
1
guadecitabine
1
Sutures
1
Surgical Instruments
1
Oxaliplatin
1
Oviposition
1
Magnetic Resonance Spectroscopy
1
Irinotecan
1
Drainage
1
Colonoscopy
1
Chemoradiotherapy
1
Cetuximab
1
Capecitabine
1
Aspirin
1
Ascorbic Acid
1
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Rectal Diseases
×
Oviposition
×
Clear all
NCT01269567
2026-05-14
GRECCAR 5
University Hospital, Bordeaux
Phase 3
Completed
494 enrolled